Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients From Uncontrolled Donation After Circulatory Death Donors With High Renal Resistive Index.

IF 1.9 Q3 TRANSPLANTATION Transplantation Direct Pub Date : 2024-05-28 eCollection Date: 2024-06-01 DOI:10.1097/TXD.0000000000001649
Maria Molina, Mario Fernández-Ruiz, Esther Gonzalez, Jimena Cabrera, Manuel Praga, Alfredo Rodriguez, Angel Tejido-Sánchez, Jose Medina-Polo, Alonso Mateos, Carlos Rubio-Chacón, Angel Sanchez, Ana Pla, Amado Andrés
{"title":"Prophylactic Anticoagulation Reduces the Risk of Kidney Graft Venous Thrombosis in Recipients From Uncontrolled Donation After Circulatory Death Donors With High Renal Resistive Index.","authors":"Maria Molina, Mario Fernández-Ruiz, Esther Gonzalez, Jimena Cabrera, Manuel Praga, Alfredo Rodriguez, Angel Tejido-Sánchez, Jose Medina-Polo, Alonso Mateos, Carlos Rubio-Chacón, Angel Sanchez, Ana Pla, Amado Andrés","doi":"10.1097/TXD.0000000000001649","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Uncontrolled donation after circulatory death (uDCD) increases organ availability for kidney transplantation (KT) at the expense of a higher risk of primary graft nonfunction (PNF). At least half of the cases of PNF are secondary to graft venous thrombosis. The potential benefit from prophylactic anticoagulation in this scenario remains unclear.</p><p><strong>Methods: </strong>In this single-center retrospective study we compared 2 consecutive cohorts of KT from uDCD with increased (≥0.8) renal resistive index (RRI) in the Doppler ultrasound examination performed within the first 24-72 h after transplantation: 36 patients did not receive anticoagulation (\"nonanticoagulation group\") and 71 patients underwent prophylactic anticoagulation until normalization of RRI in follow-up Doppler examinations (\"anticoagulation group\").</p><p><strong>Results: </strong>Anticoagulation was initiated at a median of 2 d (interquartile range, 2-3) after transplantation and maintained for a median of 12 d (interquartile range, 7-18). In 4 patients (5.6%), anticoagulation had to be prematurely stopped because of the development of a hemorrhagic complication. In comparison with the nonanticoagulation group, recipients in the anticoagulation group had a lower 2-wk cumulative incidence of graft venous thrombosis (19.4% versus 0.0%; <i>P</i> < 0.001) and PNF (19.4% versus 2.8%; <i>P</i> = 0.006). The competing risk analysis with nonthrombotic causes of PNF as the competitive event confirmed the higher risk of graft thrombosis in the nonanticoagulation group <i>(P</i> = 0.0001). The anticoagulation group had a higher incidence of macroscopic hematuria (21.1% versus 5.6%; <i>P</i> = 0.049) and blood transfusion requirements (39.4% versus 19.4%; <i>P</i> = 0.050) compared with the nonanticoagulation group. No graft losses or deaths were attributable to complications potentially associated with anticoagulation.</p><p><strong>Conclusions: </strong>Early initiation of prophylactic anticoagulation in selected KT recipients from uDCD with an early Doppler ultrasound RRI of ≥0.8 within the first 24-72 h may reduce the incidence of graft venous thrombosis as a cause of PNF.</p>","PeriodicalId":23225,"journal":{"name":"Transplantation Direct","volume":"10 6","pages":"e1649"},"PeriodicalIF":1.9000,"publicationDate":"2024-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11139466/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Direct","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/TXD.0000000000001649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Uncontrolled donation after circulatory death (uDCD) increases organ availability for kidney transplantation (KT) at the expense of a higher risk of primary graft nonfunction (PNF). At least half of the cases of PNF are secondary to graft venous thrombosis. The potential benefit from prophylactic anticoagulation in this scenario remains unclear.

Methods: In this single-center retrospective study we compared 2 consecutive cohorts of KT from uDCD with increased (≥0.8) renal resistive index (RRI) in the Doppler ultrasound examination performed within the first 24-72 h after transplantation: 36 patients did not receive anticoagulation ("nonanticoagulation group") and 71 patients underwent prophylactic anticoagulation until normalization of RRI in follow-up Doppler examinations ("anticoagulation group").

Results: Anticoagulation was initiated at a median of 2 d (interquartile range, 2-3) after transplantation and maintained for a median of 12 d (interquartile range, 7-18). In 4 patients (5.6%), anticoagulation had to be prematurely stopped because of the development of a hemorrhagic complication. In comparison with the nonanticoagulation group, recipients in the anticoagulation group had a lower 2-wk cumulative incidence of graft venous thrombosis (19.4% versus 0.0%; P < 0.001) and PNF (19.4% versus 2.8%; P = 0.006). The competing risk analysis with nonthrombotic causes of PNF as the competitive event confirmed the higher risk of graft thrombosis in the nonanticoagulation group (P = 0.0001). The anticoagulation group had a higher incidence of macroscopic hematuria (21.1% versus 5.6%; P = 0.049) and blood transfusion requirements (39.4% versus 19.4%; P = 0.050) compared with the nonanticoagulation group. No graft losses or deaths were attributable to complications potentially associated with anticoagulation.

Conclusions: Early initiation of prophylactic anticoagulation in selected KT recipients from uDCD with an early Doppler ultrasound RRI of ≥0.8 within the first 24-72 h may reduce the incidence of graft venous thrombosis as a cause of PNF.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预防性抗凝治疗可降低肾脏阻力指数高的循环死亡捐献者在无控制捐献后接受肾脏移植物静脉血栓形成的风险。
背景:非控制性循环死亡后捐献(uDCD)增加了肾移植(KT)的器官可用性,但代价是原发性移植物无功能(PNF)的风险较高。至少有一半的原发性移植物无功能病例是继发于移植物静脉血栓形成。在这种情况下,预防性抗凝治疗的潜在益处仍不明确:在这项单中心回顾性研究中,我们对移植后 24-72 小时内进行的多普勒超声检查中肾脏阻力指数(RRI)升高(≥0.8)的两组连续的尿毒症 KT 患者进行了比较:36名患者未接受抗凝治疗("非抗凝组"),71名患者接受预防性抗凝治疗,直到后续多普勒检查中RRI恢复正常("抗凝组"):抗凝治疗在移植后中位数 2 天(四分位数间距为 2-3)开始,中位数维持 12 天(四分位数间距为 7-18)。4名患者(5.6%)因出现出血性并发症而不得不提前停止抗凝治疗。与非抗凝组相比,抗凝组受者两周内移植静脉血栓的累积发生率较低(19.4% 对 0.0%;P P = 0.006)。以非血栓性 PNF 原因作为竞争事件的竞争风险分析证实,非抗凝组发生移植物血栓的风险更高(P = 0.0001)。与不抗凝组相比,抗凝组的大镜血尿发生率(21.1% 对 5.6%;P = 0.049)和输血需求(39.4% 对 19.4%;P = 0.050)更高。没有移植物损失或死亡是由于可能与抗凝相关的并发症造成的:结论:在最初的 24-72 小时内,如果多普勒超声早期 RRI ≥ 0.8,那么对经过选择的 UDCD KT 受者及早启动预防性抗凝治疗,可降低作为 PNF 原因之一的移植物静脉血栓的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transplantation Direct
Transplantation Direct TRANSPLANTATION-
CiteScore
3.40
自引率
4.30%
发文量
193
审稿时长
8 weeks
期刊最新文献
Cardiorespiratory Fitness From Cardiopulmonary Exercise Testing Is a Comprehensive Risk-stratifying Tool in Liver Transplant Candidates. Critical Considerations for Expanding Indications for Nonvascularized Rectus Fascia Transplantation: Clarifying Definitions, Techniques, and Immunogenicity. First Longitudinal Analysis of the Immunological Mechanism at Play in Uterus Transplantation. Mitigating High-risk EBV and CMV Through Kidney Paired Donation: A Survey of Potential Donor and Recipient Candidates. Outcomes Using High KDPI Kidneys in Recipients Over 65 y of Age.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1